Results 171 to 180 of about 21,407 (216)

Nonspecific Aminoglycoside Cross-Resistance of Serratia marcescens

Chemotherapy, 2009
10 of 11 clinical isolates of Serratia marcescens yielded small numbers (10-7 to 10-8) of ‘gray’ colony-type variants after selection with either amikacin, gentamicin or kanamycin, of which most proved resistant against all of the following aminoglycoside antibiotics: amikacin, gentamicin, kanamycin, neomycin, netilmicin, sisomicin and streptomycin ...
W H, Traub, P I, Fukushima
openaire   +2 more sources

Biocides – resistance, cross-resistance mechanisms and assessment

Expert Opinion on Investigational Drugs, 2012
Antibiotic resistance in bacterial pathogens has increased worldwide leading to treatment failures. Concerns have been raised about the use of biocides as a contributing factor to the risk of antimicrobial resistance (AMR) development. In vitro studies demonstrating increase in resistance have often been cited as evidence for increased risks.
Divya Prakash, Gnanadhas, Sandhya Amol, Marathe, Dipshikha, Chakravortty   +2 more
openaire   +2 more sources

Cross Resistance: Treatment and Modeling

2013
We have so far considered combination therapy under the assumption that resistance against one drug does not confer resistance to any of the other drugs in use. While this applies to many of the point mutations that induce resistance against imatinib, dastinib, and nilotinib, one mutation, T315I, confers resistance to all three drugs, i.e., there is ...
Natalia L. Komarova, Dominik Wodarz
openaire   +1 more source

Cross-Resistance in Pseudomonas aeruginosa Resistant to Phenylethanol

Journal of Pharmaceutical Sciences, 1972
The effects of benzalkonium, chlorhexidine, and phenyl-mercuric nitrate on exponential phase cultures of phenylethanol-sensitive Pseudomonas aeruginosa NCTC 6750 growing in nutrient broth and on phenylethanol-resistant cells growing in nutrient broth plus 0.2% phenylethanol v/v were determined.
R M, Richards, R J, McBride
openaire   +2 more sources

Cross-resistance of trichomonads to 5-nitroimidazole-derivatives

Experientia, 1976
The strainT. foetus KV 1/M 100, a sub-strain ofT. foetus Kv 1, was made highly resistant to metronidazole by several passages in mice under increasing drug pressure. This drug resistance was accompained by a remarkable cross-resistance to all 5-nitroimidazole-derivatives tested in vitro and in vivo.
J G, Meingassner, H, Mieth
openaire   +2 more sources

Efavirenz: resistance and cross-resistance.

International journal of clinical practice. Supplement, 1999
Resistant strains, the major cause of treatment failure in the management of HIV infection, evolve whenever virus replication is incompletely suppressed by drug therapy. In such cases, genotypic analysis of proviral DNA or phenotypic analysis of viral isolates or recombinant molecular clones can provide useful information for the clinician. With regard
openaire   +2 more sources

[Antitumor cross-resistance of trichinosis].

Voprosy onkologii, 2002
Our experiments were concerned with formation of antitumor cross-resistance by Trichinella spiralis infection in rats. Prophylactic infection was followed by an insignificant decrease in the number of 3,4-benzpyrene-induced malignant fibrous histiocytoma. It also inhibited mammary gland cancer induced by 7,12-dimethylbenzo(a)anthracene.
V I, Apanasevich, V A, Britov, Iu V, Zban'   +2 more
openaire   +1 more source

CROSS-RESISTANCE AND IMIPENEM

The Lancet, 1986
G, Calandra, F, Ricci, C, Wang, K, Brown
openaire   +2 more sources

Collateral Sensitivity and Cross-Resistance

1984
During the past 10 years cancer chemotherapy has established a valuable role in the management of many human malignancies. Its introduction has significantly improved the prognosis of patients with breast, ovarian and oat-cell lung cancers, and has resulted in long-term survivors or “cures” in cases of testicular teratomas, leukaemias, lymphomas and ...
openaire   +1 more source

In vitro Activity and Cross Resistance Studies with Cefpodoxime

Zentralblatt für Bakteriologie, 1991
On the basis of MIC determinations and appropriate MIC breakpoints, 370 pathogens showed complete cross resistance between cefpodoxime and cefuroxime axetil, cefotiam hexetil, cefixime and cefotaxime in 69.7%, 80.3%, 92.2% and 87% of the strains, respectively.
openaire   +2 more sources